MK
Mukesh Kumar Singh
About Mukesh Kumar Singh
Data last updated:
Mukesh Kumar Singh is a Director at Protek Pharmaceuticals Private Limited (since 2017). The company operates in Trading. Protek Pharmaceuticals Private Limited reported revenue of ₹6.9 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Protek Pharmaceuticals Private Limited U85191BR2012PTC018166 | Director | 21 Aug 2017 | 2012 | ₹6.9 Lakh (FY 2023) | Active |
Board colleagues of Mukesh Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sangita Kumari | 05197393 | Protek Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukesh Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukesh Kumar Singh
Mukesh Kumar Singh currently holds 1 directorship: Protek Pharmaceuticals Private Limited (Director, since 21 Aug 2017, revenue ₹6.9 Lakh (FY 2023)).
Mukesh Kumar Singh was first appointed on 21 Aug 2017 as Director at Protek Pharmaceuticals Private Limited.
The current boards of Mukesh Kumar Singh's companies include Sangita Kumari (Protek Pharmaceuticals Private Limited).